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Transglutaminases (TGs) are a family of structurally and functionally
related enzymes that catalyse calcium-dependent post-translational modifi-
cations of proteins through protein–protein crosslinking, amine incorpora-
tion, or deamidation. For many years deamidation mediated by TGs was
considered to be a side reaction, but recently substrate-specific deamida-
tions have been reported. Here we describe an optimised SDS/PAGE assay
for the easy and rapid monitoring of the TG reaction with small peptides.
The relative proportion of deamidation to transamidation was evaluated
by densitometric analysis and confirmed by nano-liquid chromatography–
nano-electrospray ionisation MS. We further investigated the effect of reac-
tion conditions on transamidation and deamidation of TG1, TG2 and
blood coagulation factor XIII A-subunit (FXIII-A) enzymes using a panel
of glutamine-containing peptide substrates. The ratio of transamidation to
deamidation was enhanced at high excess of the acyl-acceptor substrate
and increasing pH. In addition, it was influenced by peptide substrates as
well. Whereas deamidation was favoured at low cadaverine concentrations
and acidic pH, no significant effect of calcium was observed on the ratio of
transamidation/deamidation. Under our experimental conditions, deamida-
tion always occurred in vitro even at high excess of the acyl-acceptor sub-
strate, and the reaction outcome was shifted to deamidation at neutral pH.
Our results provide clear evidence of the deamidation in the TG reaction,
and may serve as an important approach for in vivo analysis of deamida-
tion to better understand the role of TGs in biological events.
Transglutaminases (TGs; EC 2.3.2.13) are widely dis-
tributed enzymes with pleiotropic functions. Nine
members have been described in mammals: ker-
atinocyte (TG1), tissue (TG2), epidermal (TG3), pros-
tate (TG4), type 5 (TG5), neuronal (TG6), type 7
(TG7), blood coagulation factor XIII A-subunit
(FXIII-A), and the catalytically inactive erythrocyte
band 4.2 protein [1].
The distribution and physiological roles of TGs have
been investigated in various cell types and tissues. TG2
is the most studied member of the TGs family. This
multifunctional protein has diverse cellular localisation
and is implicated in several physiological (regulation of
cell survival/death processes, cell adhesion, migration,
signal transduction, proliferation) and pathological pro-
cesses (coeliac disease, neurodegenerative disorders,
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fibrosis, inflammatory diseases, metabolic diseases and
cancer) [2]. TG1 mainly exists in the upper spinous and
granular layers of the skin; it is involved in the terminal
differentiation of keratinocytes by the formation of the
crosslinked cell envelope [3]. Thrombin-activated factor
FXIII-A plays an essential role in the stabilisation of
fibrin clots and in wound healing through the formation
of isopeptide bonds [4].
TGs catalyse Ca2+-dependent post-translational
modifications of proteins by generating a protein–pro-
tein crosslink (between a specific c-carboxamide group
of a glutamine and an e-amino group of a lysine side
chain), amine incorporation or deamidation. In the
first step active site cysteine reacts with the c-glutami-
nyl group of the proteins or peptides leading to the
formation of a thioester intermediate. In the second
step the acyl group is transferred to an amine substrate
resulting in the formation of an isopeptide bond or the
water can act as an alternative nucleophile leading to
site-specific deamidation of the glutamine residue [5,6].
Many of these crosslinking reactions occur within 5–
10 min, for example in case of FXIII-A between glu-
tamine (Gln398 or -399) and lysine (Lys406) residues
of the fibrin c-chains [7], whereas crosslinking of fibrin
a-chains involving Gln221, -237, -328, or -366 and
Lys208 or -606 takes place more slower [4,8].
Deamidation of glutamine and asparagine residues is
one of the most prevalent post-translational modifica-
tions and converts an uncharged amino acid to a nega-
tively charged residue introducing alternations in the
protein’s conformation. The protein function can be
changed as it is determined by its global structure, and
electrostatic protein–protein interaction can be modu-
lated as well [9]. Deamidation can occur in different
ways (non-enzymatically, by glutamines or phosphate-
activated glutaminases) regulating several biological
processes [10–12]. Moreover, cytotoxic necrotising fac-
tors in Escherichia coli and necrotoxin in Bordetella,
which are considered to be functional relatives of TGs,
can induce the formation of stress fibres by the deami-
dation of Rho proteins [13].
Deamidation by TGs was believed to be a side reac-
tion, taking place only in the absence of primary amines
or at low pH when availability of amines is limited [5],
but recently it has been reported that selective deamida-
tion in small heat shock protein [14] and bB2- and bB3-
crystallins [15] can occur in a substrate-specific manner.
Respectively, the substrate affinity and reaction condi-
tions can influence the propensity for deamidation and
transamidation [16]. Many research works are focusing
on the examination of TG crosslinking activity, which
is connected to some diseases such as fibrosis and neu-
rodegeneration. So far TG-mediated deamidation
activity has been related to coeliac disease [17,18], and
only a few reports have been published on its role in
other physiopathological processes [15,19–21]. These
studies support the potential role of TG-dependent
deamidation in the regulation of biological processes.
In this study we report an optimised SDS/PAGE
assay for the rapid and easy detection of both transami-
dated and deamidated peptides. TG1, TG2, FXIII-A
enzymes and a panel of glutamine-containing peptides
were examined to determine how the ratio of deamida-
tion to transamidation can be influenced by some reac-
tion parameters, such as affinity for substrates, amine
donor concentration, Ca2+ concentration and pH. The
identity and the relative quantity of the reaction prod-
ucts were confirmed by liquid chromatography–mass
spectrometry (LC-MS) analysis. Our results are well
correlated with the published data, cited above. Unex-
pectedly, under our reaction conditions, we found that
a particular deamidation always occurs in vitro, even at
high excess of the acyl-acceptor substrates.
Materials and methods
Materials
All materials were obtained from Sigma-Aldrich (Lyon,
France) except where otherwise indicated. Recombinant
human TG2 (rhu-TG2, cat. no. T002), recombinant human
keratinocyte TG (TG1, cat. no. T009), and recombinant
human blood coagulation factor XIII-A (FXIII-A, cat. no.
T027) were purchased from Zedira (Darmstadt, Germany).
Peptides were obtained from Covalab (Villeurbanne,
France). MilliQ water for mass spectrometry analysis was
obtained from an ELGA system (ELGA Labwater, Milli-
pore, Lyon, France).
Synthetic peptide substrates
The peptides and their derivatives [fluorescein amidite
(FAM)-labelled peptides and deaminated controls] were syn-
thesis by Covalab according to the established method for
the production of synthetic peptides using solid-phase pep-
tide synthesis described by Merrifield et al. [22]. Their purity
was determined by analytical and preparative reversed-phase
HPLC and mass spectrometry. All peptides were dissolved in
DMSO at a final concentration of 10 mM. Isoenzyme-specific
glutamine-containing peptides have been reported by Sugi-
mura et al. [23,24] and used to develop specific TG activity
assays [25,26]. K9 is a natural TG2 sequence based on
b-casein [27]. Among the natural reactive glutamine site
chains in fibrinogen a-chains a short peptide sequence con-
taining Q238 [8] was chosen for our experiments. The corre-
sponding deamidated control peptides were synthesised by
Covalab (Table 1).
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Transglutaminase reaction
Five micromolar of specific glutamine donor substrates
labelled with fluorescent FAM and cadaverine (5–1000 lM)
as an acyl acceptor were incubated with their correspond-
ing isoenzymes at 37 °C; 18 mUmL1 of TG1, TG2, or
thrombin (1 UmL1)-activated FXIII-A was applied in the
assay buffer (20 mM Tris pH 7.2 or 8.0 or MES pH 5.0 or
6.0, 150 mM NaCl, 10 mM DTT) in the presence or absence
of 10 mM EDTA. pH was 7.2, unless the effect of pH (5–8)
was examined. The enzymatic reaction was initiated by the
addition of 5 mM CaCl2, except in the experiments in which
the effect of Ca2+ was investigated (0.1–5 mM).
SDS/PAGE assay
The assay was previously reported by Kenniston et al. [28]
and modified as briefly described below. After the incubation
period the enzymatic reaction was stopped by boiling the
sample in 69 SDS-loading buffer (9.3 w/w DTT, 12 wt%
SDS, 47 v/v% glycerol, 0.06 wt% bromophenol blue in
0.5 M Tris/HCl, pH 6.8). The reaction products were run on
SDS/PAGE (15% T, 2.6% C; T represents the total concen-
tration of polyacrylamide monomer expressed in g per
100 mL and C is the percentage of bis-polyacrylamide) and
visualised by fluorescence detection (Luminescent Image
Analyzer LAS-1000 plus; Fujifilm, Dusseldorf, Germany).
Liquid chromatography–mass spectrometry
analysis
The samples were diluted 10 times in a solution of 0.1%
formic acid before analysis. Mass spectrometry analysis
was performed on a linear ion trap LTQ Velos (Thermo
Scientific, San Jose, CA, USA) with nano-electrospray ioni-
sation (ESI) source coupled in-line to a nanoRSLC system
Ultimate 3000 (Thermo Scientific, Germering, Germany).
One microlitre of sample was injected via the autosampler.
Samples were first desalted and concentrated on a reverse
phase precolumn (C18 PepMap100, 300 lm i.d. 9 5 mm,
5 lm, 100 A; Thermo Scientific) for 3 min at 20 lLmin1
with H2O/acetonitrile 98/2–0.1% formic acid. Samples were
then separated on a nanocolumn (Acclaim C18,
15 cm 9 75 lm i.d, 2 lm; Thermo Scientific). The HPLC
gradient was 5–55% solvent B (A = 5% acetonitrile, 0.1%
formic acid; B = 80% acetonitrile, 0.1% formic acid) for
30 min followed by 5 min 99% B. The total duration was
set to 50 min at a flow rate of 300 nLmin1. The oven
temperature was kept constant at 40 °C.
MS spectra were recorded in the mass range m/z 500–
1100 in positive ionisation mode; the enhanced scan rate
was used for the full MS spectrum.
Data analysis
Relative intensity of fluorescent bands was analysed with
IMAGEJ and plotted with PRISM 5 (GraphPad Software Inc.,
San Diego, CA, USA) software.
Results and discussion
Determination of transamidation and
deamidation rates by transglutaminases
Post-translational modification (PTM) is one of the
powerful regulatory elements that confer a specific
function to each protein. Dysregulation of PTMs has
been the object of a number of studies and was shown
to be associated with several diseases [29]. Among the
different type of PTMs, deamidation is unique as it
has been shown to occur in different ways: sponta-
neously, chemically and enzymatically [30].
Deamidation is the conversion of selected glutamine
and also asparagine residues into glutamate and aspar-
tate/isoaspartate through hydrolytic reaction. Such
reaction requires only water, is conditioned by both
sequence and structure, and is facilitated by physico-
chemical conditions such as high temperatures,
extreme pH or high ionic strength.
Deamidation of specific proteins such as adrenocor-
ticotropin [31] and lens crystallins [32] has been shown
to have biological repercussions due to folding changes
and/or modification of life-span. Although some pro-
teins can undergo the deamidation reaction with little
or no loss of biological activity, others do lose activity,
which can be associated with a growing list of patho-
logical phenomena such as age-related, neurological
and autoimmune diseases [33].
While in vivo deamidation of Asn to Asp was clearly
established, TG-mediated deamidation of Gln is not
fully understood and rather it was believed to be only
a side-reaction, occurring when the second substrate is
not available or at acidic pH. However, over about a
decade many reports focused on the study of the
Table 1. Sequence of the glutamine-containing amine acceptor and
deamidated control peptides.
Peptides Sequence
T26 5-FAM-1HQSYVDPWMLDH12-CONH2
T26 (Q2E) 5-FAM-1HESYVDPWMLDH12-CONH2
K9 5-FAM-1LGPGQSLVIG10-COOH
K9 (Q5E) 5-FAM-1LGPGESLVIG10-COOH
K5 5-FAM-1YEQHKLPDSWPF12-COOH
K5 (Q3E) 5-FAM-1YEEHKLPDSWPF12-COOH
F11 5-FAM-1DQMMLPWPAVAL12-COOH
F11 (Q2E) 5-FAM-1DEMMLPWPAVAL12-COOH
Fibrinogen aC 5-FAM-325TGNQNPGSPRPG336-COOH
Fibrinogen aC (Q328E) 5-FAM-325TGNENPGSPRPG336-COOH
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mechanism of hydrolysis of the specific Gln residues in
order to elucidate the role of TGs in the physiopathol-
ogy of some diseases and coeliac disease in particular.
In order to evaluate the deamidation reaction of TG
to convert Gln to Glu, several methods were used
depending on whether the Gln substrates were natural
(e.g. proteins) or synthetic (e.g. peptides). In the case
of proteins, deamidations were analysed through
molecular modelling and biological activity [34–36]
whereas synthetic peptides were analysed by various
techniques such as mass spectrometry (MS and LC-
MS), size exclusion chromatography, capillary elec-
trophoresis, HPLC, 2D gels and western blot [14].
In this work we optimised an electrophoresis assay
based on SDS/PAGE for the rapid and easy detection
of both transamidated and deamidated peptides. All
reaction products of FAM fluorescein-labelled peptides
could be simultaneously detected with high resolution
and specificity. The relative ratio of deamidation and
transamidation was evaluated by densitometric analy-
sis (Fig. 1B,E). The identity and the proportion of the
reaction products were confirmed by nano-LC–nano-
ESI-MS analysis. The relative quantities were calcu-
lated from extraction ions chromatogram areas of the
doubly charged ions of each species (Fig. 1C,F, Figs
S1, S2, Table S1), assuming that all the species have
the same response factors. The data obtained by LC-
MS are in good correlation with the results of densito-
metric analysis, indicating that the optimised SDS/
PAGE assay is a reliable method for the semi-quanti-
tative examination of both transamidated and deami-
dated reaction products.
Catalytic activity of transglutaminases always
generates deamidated peptide products
In this study TG1, TG2, FXIII-A enzymes and five
glutamine-containing peptides (K5, T26, F11, K9 and
aC(Q328)) (Table 1) were examined to determine how
the ratio of deamidation to transamidation can be
influenced by some reaction parameters such as sub-
strates affinity, amine donor concentration, Ca2+ con-
centration and pH. K5 [23], T26 and F11 [24] were
described as isoenzymes preferring glutamine sub-
strates having high affinity to TG1, TG2 and FXIII-A,
respectively, whereas K9 [27] and fibrinogen aC(Q328)
peptides [8] are known as natural glutamine donor
substrates for TG2 and FXIII-A.
Fig. 1. Relative quantification of TG reaction products using SDS/PAGE analysis and fluorescence detection. TG2 was incubated with FAM-
K9 peptide (A–C), thrombin activated FXIII-A with FAM-fibrinogen aC(325–336) peptide (D–F) and with cadaverine in the presence of Ca2+
for 20 min (TG2) or 5 h (FXIII-A) at 37 °C. Q, reactive glutamine-containing control peptide; E, deamidated control peptide. (B, E)
Densitometry analysis of the SDS/PAGE. (C, F) Relative quantification of the reaction products by nano-LC–nano-ESI-MS.
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Applying high excess of the amine donor substrate
(cadaverine), the ratio of transamidation to deamida-
tion was increased, whereas deamidation was favoured
at low cadaverine concentrations. In the absence of the
second substrate, no crosslinked product was detected
(Fig. 2). In addition this effect appeared to be sub-
strate dependent and confirm the results obtained by
the group of Sollid [16]. TG2 transamidase activity
was rather higher with K9 (Fig. 2B) than with T26
peptide (Fig. 2C) indicating better recognition of natu-
ral glutamine substrate. This difference was not
observed with FXIII-A as the reactivity is higher with
F11 than with fibrinogen aC(Q328) peptides. Indeed
upon the same reaction conditions the relative ratio of
deamidated/transamidated fibrinogen aC(Q328) pep-
tide was increased (Fig. 2E) whereas F11 peptide was
preferred for transamidation (Fig. 2D). This slight dif-
ference in the deamidation/transamidation rate may be
explained by the influence of the neighbouring amino
acids relative to the targeted Gln and may affect the
affinity of the enzymes. Indeed Boros et al. [15]
reported that TG2 can process site-specific deamidation,
and a proline at position +2 to the specific glutamine
residue may positively influence deamidation [35].
Moreover, the results reveal that TG2- and FXIII-
A-catalysed substrate deamidation could always occur
as an excess of primary amine did not completely inhi-
bit deamidation (Fig. 1B–E). However, deamidation
by TG1 is less obvious in all conditions studied and
this could explain why K5 may not be good substrate
of this enzyme for deamidation (Fig. 2A). Using natu-
ral and good substrate for TG1 will be of interest in
completing this work.
Effect of pH on the transglutaminase-catalysed
deamidation
Fleckenstein et al. [35] described that the TG2-cata-
lysed reaction of gliadin substrate is strongly influ-
enced by pH. Here, we extended the investigation for
two other isoenzymes and five peptide substrates as
detailed in the Materials and methods (Fig. 3). In all
cases the transamidation and deamidation reactions
were analysed in buffers with pH values ranging from
5 to 8. TG1 (Fig. 3A) and FXIII-A (Fig. 3D,E) seem
to not be active at acidic pH, but at pH 6.0 fibrinogen
aC(Q328) peptide was deamidated in the majority of
cases (Fig. 3E). At pH 8.0 all the peptides were con-
verted to transamidated forms by all the corresponding
enzymes. In the condition of neutral pH, TG1 was not
active due probably to the low kinetic reaction,
whereas TG2 and FXIII-A were able to convert the
peptides to transamidated and deamidated products.
The proportion of each product depends on the type
of the enzyme and also the glutamine substrate. T26
was highly deamidated by TG2 whereas the natural
substrate K9 was in the majority of cases transami-
dated (Fig. 3B,C) and with FXIII-A the deamidation
was more important than the transamidation for both
substrates (Fig. 3D,E). These results further demon-
strate that the rate of the transamidation reactions is
significantly increased at alkaline pH indicating the
importance of the nucleophily of the amine, which
must be unprotonated. As the pKa of the cadaverine
amine is around 10, it is expected that the transamida-
tion reaction can be favoured over deamidation.
Indeed in the report of Fleckenstein et al. [35] using 5-
(biotinamido)penthylamine as an amine donor with
pKa around 10.5, a general base-catalysed deacylation
mechanism was proposed for the transamidation reac-
tion through a nucleophilic attack on the thiol ester
Fig. 2. Monitoring of TG reaction at different cadaverine
concentrations by SDS/PAGE analysis. TG1 was incubated with
FAM-K5 (A), TG2 with FAM-T26 (B) and FAM-K9 (C), thrombin
activated FXIII-A with FAM-F11 (D), FAM-fibrinogen aC(325–336)
(E) glutamine donor peptides and with cadaverine in the presence
of Ca2+ for 20 min (A–D) or 5 h (E) at 37 °C. The reaction products
were separated by SDS/PAGE and visualised by fluorescence
detection. Q, reactive glutamine-containing control peptide; E,
deamidated control peptide.
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intermediate. Increasing the pH to narrow the pKa of
the base would decrease its protonation, and conse-
quently the competition by water molecules is blocked
explaining the increase of transamidation rate.
Effect of Ca2+ on the transglutaminase-catalysed
deamidation
It is well known that Ca2+ is required for the activa-
tion of TGs through inducing a large conformational
change in the enzyme structure [37,38]. Because of the
large difference in the open and closed conformations,
we hypothesised that depending on Ca2+ binding,
more transient conformers with a different hydrody-
namic radius can be exhibited. Probably at lower
Ca2+ concentrations the substrate-binding channel
could be particularly covered and the entrance of the
second substrate could be inhibited resulting on the
deamidation of the glutamine donor substrate via
hydrolysis. Transamidation and deamidation were
analysed with different Ca2+ concentrations ranging
from 0.1 to 5 mM as described in Materials and meth-
ods (Fig. 4). At lower Ca2+ concentration (0.1–
0.2 mM) TG2 seems to not be active (Fig. 4B,C)
whereas TG1 converted the majority of K5 to
transamidated product (Fig. 4A). With FXIII-A we
observed high activity with F11 substrate (Fig. 4D)
and low activity with natural substrate (Fig. 4E),
which can be explained by the high affinity of the
enzyme to the synthetic substrate. By increasing Ca2+
concentration the enzymes were more active and both
transamidation and deamidation occurred at a differ-
ent rate depending on the Gln substrate: transamida-
tion was observed more with TG1 and TG2 using K5
and T26 substrates, respectively, and more deamida-
tion was obtained with TG2 and FXIII-A using K9
and fibrinogen aC(Q328). Based on these results no
significant effect of calcium on the ratio of transamida-
tion/deamidation was obtained.
In conclusion, our assay based on SDS/PAGE pro-
vides an easy and rapid method for monitoring the
TG reaction with synthetic small peptides. The
Fig. 3. Monitoring of TG reaction at different pH values by SDS/
PAGE analysis. TG1 was incubated with FAM-K5 (A), TG2 with
FAM-T26 (B) and FAM-K9 (C), thrombin-activated FXIII-A with
FAM-F11 (D) and FAM-fibrinogen aC(325–336) (E) glutamine
donor peptides and with cadaverine as acyl-acceptor in the
presence (EDTA) or absence (+ EDTA) of Ca2+ at pH 5–8 for
20 min (A–D) or 5 h (E) at 37 °C. The reaction products were
separated by SDS/PAGE and visualised by fluorescence
detection. Q, reactive glutamine-containing control peptide; E,
deamidated control peptide.
Fig. 4. Monitoring of TG reaction at different Ca2+ concentrations
by SDS/PAGE analysis. TG1 was incubated with FAM-K5 (A), TG2
with FAM-T26 (B) and FAM-K9 (C), thrombin-activated FXIII-A with
FAM-F11 (D) and FAM-fibrinogen aC(325–336) (E) glutamine donor
peptides and with cadaverine as acyl-acceptor at different Ca2+
concentrations for 20 min (A–D) or 5 h (E) at 37 °C. The reaction
products were separated by SDS/PAGE and visualised by
fluorescence detection. Q, reactive glutamine-containing control
peptide; E, deamidated control peptide.
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fractions of native, deamidated and transamidated
peptides can be successfully separated and their rates
were confirmed by nano-LC–nano-ESI-MS. Under our
experimental conditions we noticed that a particular
deamidation always occurs, even at high molar con-
centration (148–200-fold molar excess) of amine donor
substrate and it is preferred at low to neutral pH.
These data provide further evidence for the simultane-
ous reactions of transamidation and deamidation, but
further work will be needed to confirm this in vitro
and in vivo at the endogenous proteins level. Knowl-
edge of the in vivo regulation of transamidation versus
deamidation is therefore crucial for the elucidation of
the TG enigma. Most of the TG activity assays are
based on detection of the transamidated products.
Since the deamidation is no longer believed to be a
side reaction, TG activity cannot be accurately evalu-
ated only by detecting the crosslinked products.
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Fig. S1. Nano-LC–nano-ESI-MS analysis transglutam-
inase reaction products eXtracted Ions Chro-
matograms (XIC). TG2 was incubated with FAM-K9
peptide in the absence (a) or with 150 lM of cadaver-
ine (b) in the presence of Ca2+ for 20 min at 37 °C.
From top to bottom, XICs of m/z 649.84 from FAM-
K9 peptide native form, m/z 692.40 from FAM-K9
peptide transamidated form and m/z 650.32 from
FAM-K9 peptide deamidated form (MA = peak area).
Fig. S2. Nano-LC–nano-ESI-MS analysis of transglu-
taminase reaction products eXtracted Ions Chro-
matograms (XIC). Thrombin-activated FXIII-A was
incubated with FAM-fibrinogen aC(325–336) peptide
in the absence (a) or with 1000 lM of cadaverine (b) in
the presence of Ca2+ for 5 h at 37 °C. From top to
bottom, XICs of m/z 770.36 from FAM-fibrinogen aC
(325–336) peptide native form, m/z 770.88 from FAM-
fibrinogen aC(325–336) peptide deamidated form and
m/z 812.88 from FAM-fibrinogen aC(325–336) peptide
transamidated form (MA = peak area).
Table S1. Molecular mass and m/z (mass-to-charge
ratio) of K9 and fibrinogen aC(325–336) glutamine
donor peptides.
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